Why did the Fed cut interest rates today?
How is Tesla addressing door handle safety issues?
What impact does China’s Nvidia chip ban have?
Why was Jimmy Kimmel's show pulled by ABC?
How will Meta's new AI glasses affect the market?
What caused Cracker Barrel’s sales and stock slump?
Why are Starbucks workers suing over new dress code?
A new contender just rattled the obesity drug market
fastcompany.com/91405981/a-new-contender-just-rattled-the-obesity-drug-market
An experimental GLP-1 pill from Eli Lilly just outperformed Novo Nordisk’s oral semaglutide. In a new study, Eli Lilly’s oral pill, orforglipron, helped lower diabetes patients blood sugar more and weight better than Novo Nordisk’s (sold under brand names Ozempic, Rybelsus, and Wegovy).…
This story appeared on fastcompany.com, 2025-09-17 18:40:00.